Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T00:02:09.907Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient Attitudes Regarding Participation in Studies of Antimicrobial Resistance

Published online by Cambridge University Press:  02 January 2015

Pam Tolomeo ,
Mary Wheeler ,
Joshua P. Metlay ,
Katrina Armstrong ,
Neil O. Fishman ,
Warren B. Bilker  and
Ebbing Lautenbach
Pam Tolomeo
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania
Mary Wheeler
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania Center for Bioethics, Department of Medicine, Philadelphia, Pennsylvania
Joshua P. Metlay
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania Center for Education and Research on Therapeutics, Department of Medicine, Philadelphia, Pennsylvania Divisions of General Internal Medicine, Department of Medicine, Philadelphia, Pennsylvania Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Department of Veterans Affairs, Philadelphia, Pennsylvania
Katrina Armstrong
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania Divisions of General Internal Medicine, Department of Medicine, Philadelphia, Pennsylvania Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Neil O. Fishman
Affiliation:
Center for Education and Research on Therapeutics, Department of Medicine, Philadelphia, Pennsylvania Infectious Diseases, Department of Medicine, Philadelphia, Pennsylvania
Warren B. Bilker
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania Center for Education and Research on Therapeutics, Department of Medicine, Philadelphia, Pennsylvania Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Ebbing Lautenbach*
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Department of Medicine, Philadelphia, Pennsylvania Center for Education and Research on Therapeutics, Department of Medicine, Philadelphia, Pennsylvania Infectious Diseases, Department of Medicine, Philadelphia, Pennsylvania Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
*
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 825 Blockley Hall, 423 Guardian Dr., Philadelphia, PA 19104-6021 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

A number of recent studies of antimicrobial resistance have focused on the role of antimicrobial-resistant pathogens that colonize the gastrointestinal tract. However, participation rates have been low in studies that involve fecal sampling. Attitudes toward such studies among potential study participants have not been assessed.

Methods.

We conducted a cross-sectional survey, enrolling 3 groups of inpatients from a large academic center. Group 1 consisted of patients who had previously participated in a cohort study of fluoroquinolone-resistant Escherichia coli, which involved the collection of perirectal swab samples. Group 2 consisted of patients who had previously refused to participate in the study of fluoroquinolone-resistant E. coli. Group 3 consisted of patients who had never been asked to participate in the study of the fluoroquinolone-resistant E. coli. The survey assessed patients' attitudes and beliefs regarding medical research and their willingness to consent to collection of a perirectal swab sample. Response options were recorded on a 5-point Likert scale. The Fisher exact test was used to compare dichotomized responses across study groups.

Results.

A total of 90 patients were surveyed: there were 29 in group 1 and in group 2 and 32 in group 3. Of 90 patients, 31 (35%) believed researchers might run additional tests on collected samples without informing the patient, whereas 25 (27%) believed persons other than the research team might gain access to study results. The belief that a person could get sicker as a result of a having a perirectal swab sample collected was significantly more common among patients who had previously refused to participate in the fluoroquinolone-resistant E. coli study.

Conclusion.

This study highlights important beliefs and attitudes that are associated with the likelihood of participating in studies of antimicrobial resistance. Explicitly addressing these concerns with eligible patients is critical to optimize participation in future studies.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 2 , February 2008 , pp. 155 - 159
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.Google Scholar
2.Donskey, CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219–226.Google Scholar
3.Lautenbach, E, Harris, AD, Perencevich, EN, Nachamkin, I, Tolomeo, P, Metlay, JP. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother 2005;49:798–800.Google Scholar
4.Carratala, J, Fernandez-Sevilla, A, Tubau, F, Dominguez, MA, Gudiol, F. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 1996;40:503–505.Google Scholar
5.Lautenbach, E, Fishman, NO, Metlay, JP, et al.Phenotypic and genotypk characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis 2006;194:79–85.Google Scholar
6.Wilets, I, O'Rourke, M, Nassisi, D. How patients and visitors to an urban emergency department view clinical research. Acad Emerg Med 2003;10: 1081–1085.Google Scholar
7.Napoles-Springer, AM, Grumbach, K, Alexander, M, et al.Clinical research with older African Americans and Latinos: perspectives from the community. Res Aging 2000;22:668–691.Google Scholar
8.Corbie-Smith, G, Thomas, SB, St George, DM. Distrust, race, and research. Arch Intern Med 2002;162:2458–2463.Google Scholar
9.Halpern, SD, Karlawish, JH, Casaren, D, Berlin, JA, Asch, DA. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med 2004;164: 801–803.Google Scholar